REGULUS THERAPEUTICS INC (RGLS) Stock Balance Sheet
NASDAQ:RGLS - Nasdaq - US75915K3095 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 49.46M | 38.53M | 23.77M | 24.23M | 60.38M | |||
| Marketable Securities | 15.91M | 37.25M | 0.00 | 14.93M | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Current Assets | 6.33M | 6.57M | 4.41M | 4.92M | 4.85M | |||
| Total Current Assets | 71.69M | 82.34M | 28.18M | 44.08M | 65.23M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.11M | 1.81M | 2.54M | 2.58M | 2.85M | |||
| Intangibles | 23.00K | 25.00K | 33.00K | 62.00K | 83.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | 0.00 | 291.00K | |||
| Total Non-Current Assets | 3.13M | 1.84M | 2.57M | 2.64M | 3.22M | |||
| TOTAL ASSETS | 74.83M | 84.18M | 30.75M | 46.72M | 68.45M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 1.33M | 4.51M | 0.00 | |||
| Accrued Expenses | 3.40M | 5.40M | 4.59M | 4.42M | 3.65M | |||
| Accounts Payable | 200.00K | 947.00K | 204.00K | 175.00K | 285.00K | |||
| Other Current Liabilities | 797.00K | 1.15M | 2.38M | 2.55M | 1.29M | |||
| Total Current Liabilities | 4.40M | 7.50M | 8.51M | 11.66M | 5.23M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 4.67M | |||
| Other Non-Current Liabilities | 1.40M | 274.00K | 1.05M | 1.77M | 3.60M | |||
| Total Non-Current Liabilities | 1.40M | 274.00K | 1.05M | 1.77M | 8.27M | |||
| TOTAL LIABILITIES | 5.80M | 7.77M | 9.56M | 13.43M | 13.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -569.21M | -559.57M | -513.21M | -483.18M | -454.85M | |||
| Additional Paid In Capital | 638.15M | 635.86M | 534.38M | 516.46M | 509.66M | |||
| Common Shares | 71.00K | 71.00K | 25.00K | 22.00K | 151.00K | |||
| Other Shareholders' Equity | 10.00K | 50.00K | 0.00 | -12.00K | N/A | |||
| Shares Outstanding | 66.28M | 65.50M | 20.22M | 16.84M | 14.60M | |||
| Tangible Book Value per Share | 1.04 | 1.17 | 1.05 | 1.97 | 3.76 | |||
| Total Shareholders' Equity | 69.03M | 76.41M | 21.19M | 33.29M | 54.96M | |||
| TOTAL LIABILITIES AND EQUITY | 74.83M | 84.18M | 30.75M | 46.72M | 68.45M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.09 | |||
| Current Ratio | 16.31 | 10.98 | 3.31 | 3.78 | 12.48 | |||
| Return On Assets (ROA) | -63.51% | -55.07% | -97.68% | -60.63% | -40.62% | |||
| Return On Equity (ROE) | -68.85% | -60.67% | -141.77% | -85.08% | -50.60% | |||
All data in USD , ROIC based on taxRate of 0.21